MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2016 International Congress

    Patient-centered educational intervention using hand-held electronic devices

    N. Hellmers, A. Hanineva, J.C. Stribling, J. Carter, C. Henchliffe (New York, NY, USA)

    Objective: To examine feasibility, usability and initial efficacy of an e-learning intervention, using an interactive tablet-based slideshow with audio/video and quizzes. Background: Mobile tablet and…
  • 2016 International Congress

    Development and external validation of a prognostic model of mortality in Parkinson’s disease

    A.D. Macleod, I. Dalen, O.B. Tysnes, J.P. Larsen, C.E. Counsell (Aberdeen, United Kingdom)

    Objective: To develop and validate a prognostic model to predict mortality in Parkinson's disease (PD). Background: Most previous prognostic studies in PD have used unrepresentative…
  • 2016 International Congress

    Evaluation of the [ 99mTc] – TRODAT- 1 SPECT in the diagnosis of Parkinson’s disease and other movement disorders

    G. Fabiani, R. Martins Filho, H.A.G. Teive (Campina Grande do Sul, Brazil)

    Objective: Evaluation of the [ 99mTc] - TRODAT- 1 SPECT in the diagnosis of PD and other MD. Create a DATA bank for our population.…
  • 2016 International Congress

    Patients’ employment status and quality of life affect caregivers burden in Parkinson’s disease in Singapore

    K.M. Prakash, N.V. Nadkarni, W.K. Lye, E.C. Lim, E.K. Tan (Singapore, Singapore)

    Objective: This study was aimed at assessing caregiver burden (CB) and analyzing its relationship with patient's sociodemographic, motor and non-motor severity as well as health-related…
  • 2016 International Congress

    How long is the wait to see a Parkinson’s disease specialist in the United States?

    S.G. Reich, K. Holmes, J. Martello, K. Maki (Baltimore, MD, USA)

    Objective: To investigate the wait time to see a PD specialist in the US. Background: PD patients who see a specialist have better outcomes and…
  • 2016 International Congress

    Testing feasibility and utility of remote data capture technology to assess Parkinson’s disease

    J. Carter, N. Hellmers, A. Hanineva, C. Henchcliffe (New York, NY, USA)

    Objective: To test feasibility and utility of home-based video-recording uploaded from a mobile device app to a cloud-based storage platform, in order to quantitate motor…
  • 2016 International Congress

    Transcriptional profile of blood leukocyte in Parkinson’s disease patients after multi-modal exercise and tai chi training

    L. Jin, Y. Hu, T. Zhang, K. Zhang, Z. Nie, F. Chen, Q. Cai, S. Li (Shanghai, People's Republic of China)

    Objective: With next-generation sequencing, we want to get a comprehensive characterization of circulating leukocyte in patients with PD, to interrogate the shared molecular processes perturbed…
  • 2016 International Congress

    Familial Parkinson’s disease in the Province of Quebec

    L.L. Farrell, E. Pourcher, E. Nosova, M. McKenzie, I. Guella, D.M. Evans, C. Déry, M.J. Farrer (Vancouver, BC, Canada)

    Objective: We describe clinical, genealogic and genetic studies in several families with multi-incident Parkinson's disease (PD). Background: PD is a multifactorial trait for which components…
  • 2016 International Congress

    A descriptive study on the safety and feasibility of mesenchymal stem cell therapy for Parkinson’s disease: A case series

    M.J.O.V. Buensalido, J.J.A. Tiongson (Pasig City, Philippines)

    Objective: To describe the incidence and severity of infusion-related adverse events of mesenchymal stem cells (MSC) for Parkinson's disease in patients who underwent treatment. Background:…
  • 2016 International Congress

    Cerebellar atrophy in Parkinson’s disease and its implication for network connectivity

    J.M. Shine, C. O'Callaghan, M. Hornberger, G.M. Halliday, S.J.G. Lewis (Palo Alto, CA, USA)

    Objective: To determine the effect of cerebellar atrophy on resting-state network abnormalities in individuals with Parkinson's disease. Background: In Parkinson's disease, the cerebellum is a…
  • « Previous Page
  • 1
  • …
  • 415
  • 416
  • 417
  • 418
  • 419
  • …
  • 425
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley